Chemical | Study No. | Vehicle | Species | Site | Membrane | Area (cm2) | Cell Type | Exposure Time (h) | Length of Study(h) | % Recovery | % Penetrated | % Absorbed | s-s-flux (mcrg/cm2/h) | kp (cm/h) | n | Lag Time (h) | Ref.No |
Fluazifop-butyl | 639 | Commercial Emulsifyable Concentrate | Human | Abdomen | Isolated Epidermis | 2.5 | Static | 24 | 24 | | | 2.2 | | | | | 75 |
Fluazifop-butyl | 640 | Commercial Emulsifyable Concentrate | Human | Abdomen | Isolated Epidermis | 2.5 | Static | 24 | 24 | | | 0.28 | | | | | 75 |
Fluazifop-butyl | 641 | Commercial Emulsifyable Concentrate | Human | Abdomen | Isolated Epidermis | 2.5 | Static | 24 | 24 | | | 0.32 | | | | | 75 |
Fluazifop-butyl | 642 | Commercial Emulsifyable Concentrate | Human | Abdomen | Isolated Epidermis | 2.5 | Static | 24 | 24 | | | 2.76 | | | | | 75 |
Fluazifop-butyl | 643 | Commercial Emulsifyable Concentrate | Human | Abdomen | Isolated Epidermis | 2.5 | Static | 24 | 24 | | | 2.32 | | | | | 75 |
Fluazifop-butyl | 644 | Commercial Emulsifyable Concentrate | Human | Abdomen | Isolated Epidermis | 2.5 | Static | 24 | 24 | | | 0.472 | | | | | 75 |
Fluazifop-butyl | 645 | Commercial Emulsifyable Concentrate | Human | Abdomen | Isolated Epidermis | 2.5 | Static | 24 | 24 | | | 2.4 | | | | | 75 |
Fluazifop-butyl | 646 | Commercial Emulsifyable Concentrate | Human | Abdomen | Isolated Epidermis | 2.5 | Static | 24 | 24 | | | 0.28 | | | | | 75 |
Previous Next |